Senseonics Holdings, Inc. (SENS) Stock Score, Valuation & Financial Research
Senseonics Holdings, Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 22/100.
Quick answer for SENS
Senseonics Holdings, Inc. currently has a Wall Street Score of 22/100. The stored market price is $8.71. Its financial score is 23/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Senseonics Holdings, Inc. does
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement
SENS financial snapshot
- Wall Street Score:
- 22/100
- Current price:
- $8.71
- Market capitalization:
- $364.0M
- Revenue:
- $40.7M
- Net income:
- $-87.2M
- Free cash flow:
- $-60.2M
- Cash:
- $29.9M
- Total debt:
- $43.1M
- EPS:
- -1.66
- Financial score:
- 23/100
- Valuation score:
- 0/100
- Revenue score:
- 37/100
What stands out
- Reported year-over-year revenue growth is +0.2%.
- Free cash flow is $-60.2M, showing cash burn in the current stored period.
- The balance sheet shows $29.9M of cash versus $43.1M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 23/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research SENS
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.